KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $694,376 | -23.6% | 4,107 | -2.0% | 0.45% | -18.1% |
| Q2 2023 | $908,504 | +16.5% | 4,190 | -2.4% | 0.55% | +10.5% |
| Q1 2023 | $779,514 | -1.0% | 4,292 | +7.1% | 0.50% | -9.7% |
| Q4 2022 | $787,244 | -33.3% | 4,006 | -23.7% | 0.55% | -35.3% |
| Q3 2022 | $1,181,000 | +62.4% | 5,251 | -8.6% | 0.85% | +64.5% |
| Q2 2022 | $727,000 | -6.9% | 5,747 | -6.7% | 0.52% | +4.7% |
| Q1 2022 | $781,000 | -6.8% | 6,163 | -3.7% | 0.49% | -0.6% |
| Q4 2021 | $838,000 | +0.8% | 6,400 | -5.8% | 0.50% | -7.8% |
| Q3 2021 | $831,000 | +13.5% | 6,791 | +5.7% | 0.54% | +8.2% |
| Q2 2021 | $732,000 | +262.4% | 6,426 | +282.0% | 0.50% | +233.6% |
| Q1 2021 | $202,000 | – | 1,682 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |